By Rose Krebs ( March 29, 2019, 7:48 PM EDT) -- A Teva Pharmaceuticals Ltd. subsidiary did not infringe Orexo AB's opioid addiction treatment drug Zubsolv with two generic drugs, a Delaware federal jury ruled Friday, after a five-day trial over Orexo's infringement case that sought at least $41 million in damages....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.